secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2026-09-18T20:16:04+00:00
Accession:  0001437749-26-030751
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Filana Therapeutics receives Nasdaq delisting notice over sub-$1.00 bid price
-----------------------------------------------------------------------------

- Received Nasdaq notice Sept 17, 2026; bid price below $1.00 for 30 consecutive business days.
- Non-compliant with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.
- Has 180 calendar days until March 16, 2027 to regain compliance.
- Must close at $1.00+ for 10 consecutive business days; second 180-day period possible.
- Stock continues trading on Nasdaq Capital Market under symbol FLNA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/0001437749-26-030751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/sava20260918_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer